Effects of xuezhikang versus pravastatin on triglyceride level in patients with T2DM and dyslipidemia: study protocol for a multicenter randomized controlled trial
CONCLUSION: This study will evaluate the effect of a 6-week treatment with xuezhikang compared with pravastatin on fasting and postprandial TG levels and other blood lipid parameters in patients with T2DM and dyslipidemia without atherosclerotic cardiovascular disease (ASCVD). The results will provide more information on optimizing the lipid control of patients with diabetes in the primary prevention of ASCVD.PMID:36998136 | DOI:10.2174/1570161121666230328110215
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Jin Xu Liyuan Zhu Yingying Xie Miao Zhang Zixi Xiao Rongkai Su Tie Wen Ling Liu Source Type: research
More News: Cardiology | Cardiovascular | China Health | Cholesterol | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Heart Attack | Heart Disease | Nutrition | Pravastatin | Red Yeast Rice | Statin Therapy | Study